Public market insider buying at Wesana Health Holdings (WESA)

Public market insider buying at Wesana Health Holdings (C:WESA)

The K2 Principal Fund L.P., a 10% Holder, acquired 48,000 Common Shares on a direct ownership basis at prices ranging from $3.248 to $3.303 between September 20th, 2021 and September 23rd, 2021. This represents a $156,904 investment into the company's shares and an account share holdings change of 3.0%.

Wesana Health Holdings is in the Biotechnology & Medical Research Sub Industry Group under the Healthcare Sector.

Wesana Health Holdings Inc, formerly Debut Diamonds Inc. (Debut), is a Canada-based life science company. The Company is engaged in development and delivery of psychedelic and naturally sourced therapies to treat traumatic brain injury (TBI) and related conditions. It develops evidence-based formulations and protocols for patients to overcome neurological, psychological and mental health ailments caused by trauma.